JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB134917

Anti-LEC antibody [EPR4452(2)]

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Recombinant Monoclonal LEC antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.

View Alternative Names

ILINCK, NCC4, SCYA16, CCL16, C-C motif chemokine 16, Chemokine CC-4, Chemokine LEC, IL-10-inducible chemokine, LCC-1, Liver-expressed chemokine, Lymphocyte and monocyte chemoattractant, Monotactin-1, NCC-4, Small-inducible cytokine A16, HCC-4, LMC, MTN-1

2 Images
Western blot - Anti-LEC antibody [EPR4452(2)] (AB134917)
  • WB

Unknown

Western blot - Anti-LEC antibody [EPR4452(2)] (AB134917)

All lanes:

Western blot - Anti-LEC antibody [EPR4452(2)] (ab134917) at 1/10000 dilution

All lanes:

Human LEC recombinant protein (10ng)

Secondary

All lanes:

Secondary Goat-anti-rabbit HRP at 1/2000 dilution

Predicted band size: 14 kDa

true

OI-RD Scanning - Anti-LEC antibody [EPR4452(2)] (AB134917)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-LEC antibody [EPR4452(2)] (AB134917)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR4452(2)

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/50000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" } } }

Product details

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

LEC also known as CCL16 is a chemokine protein that functions in the immune system. This protein weighs approximately 22 kDa and resides mainly in the liver and peripheral blood leukocytes. LEC belongs to the CC chemokine family characterized by two adjacent cysteine residues. The protein connects with other cellular systems to modulate immune responses. Antibodies like anti-LEC can detect it effectively and commercial products such as LEC BSA and LEC custom products aid in its study.
Biological function summary

LEC performs vital roles in immune cell signaling and chemotaxis. It binds specifically to certain chemokine receptors on target cells initiating signaling cascades that recruit lymphocytes to infected or inflamed tissues. LEC functions as part of a larger complex that includes other chemokines to coordinate immune responses. Its expression and activity influence various immune functions which makes its regulation significant for maintaining healthy immune system operation.

Pathways

LEC acts within immune signaling pathways and inflammation-related processes. It plays essential parts in pathways like the chemokine signaling pathway where it interacts with other proteins such as CCR1 and CCR2 chemokine receptors. Through these interactions LEC contributes to the recruitment and activation of specific immune cell subtypes facilitating a coordinated response to inflammation or infection.

LEC connects to conditions involving immune dysregulation like rheumatoid arthritis and liver diseases. In rheumatoid arthritis LEC levels can affect inflammation and tissue damage often in concert with proteins like TNF-alpha. In liver diseases altered LEC expression may relate to liver fibrosis with connections to proteins such as TGF-beta. Understanding LEC's role in these conditions can lead to better therapeutic strategies targeting the chemokine network.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Shows chemotactic activity for lymphocytes and monocytes but not neutrophils. Also shows potent myelosuppressive activity, suppresses proliferation of myeloid progenitor cells. Recombinant SCYA16 shows chemotactic activity for monocytes and THP-1 monocytes, but not for resting lymphocytes and neutrophils. Induces a calcium flux in THP-1 cells that were desensitized by prior expression to RANTES.
See full target information CCL16

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Clinical epigenetics 17:129 PubMed40696470

2025

Targeting PRMT1-mediated methylation of TAF15 to protect against myocardial infarction by inhibiting ferroptosis via the GPX4/NRF2 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Guanshen Huang,Liwei He,Bishan Liang,Mingjian Gao,Jianming Huang,Hao Xia,Xinyu Li,Hai Li,Yunjun Ruan
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com